Basic Fildena Extra Power Information

• INN (International Nonproprietary Name): Sildenafil — All formulations of Fildena Extra Power are based on sildenafil citrate, a phosphodiesterase‑5 (PDE‑5) inhibitor widely used for erectile dysfunction and pulmonary arterial hypertension.
• Brand Names Available In Canada (English): Fildena Extra Power is typically not authorised in Canada and commonly lacks a Canadian Drug Identification Number (DIN); originator Viagra and Health Canada–approved sildenafil generics are the authorised brands.
• ATC Code: G04BE03 — Sildenafil (Urologicals; Drugs Used In Erectile Dysfunction; Sildenafil).
• Forms & Dosages: Tablet forms reported include a 150 mg “Extra Power” strength and standard strengths of 25 mg, 50 mg, and 100 mg, with 150 mg promoted for patients unresponsive to lower doses.
• Manufacturers In Canada (English): Not specified; the listed manufacturer for Fildena Extra Power is Fortune Healthcare (India).
• Registration Status In Canada (English): Not authorised under the Fildena name in most western markets; only originator Viagra and approved generics with DINs are authorised for sale in Canada.
• OTC / Rx Classification: Prescription Only (Rx) — medical evaluation and a valid prescription are required.

Key Findings From Recent Trials

Patients and clinicians often ask whether higher doses really help when 100 mg fails.

Recent systematic reviews and meta‑analyses from 2022–2024 reaffirm sildenafil’s efficacy versus placebo for erectile dysfunction across age groups, with the largest effect sizes reported for intercourse satisfaction and erection rigidity.

Telemedicine‑driven prescribing combined with real‑world registry data in high‑income countries shows increased use of generics since 2020 and ongoing monitoring for cardiovascular adverse events.

Clinical trial endpoints consistently show improvement in International Index of Erectile Function (IIEF) scores with sildenafil compared with placebo.

Benefit beyond the 100 mg dose appears to diminish for most patients, while high‑dose (≥150 mg) evidence is limited and mostly from small non‑randomised series.

Post‑market surveillance between 2022 and 2024 reiterates known safety signals: hypotension with nitrates, transient visual disturbances, and rare priapism.

Purchasing from online international suppliers raises additional concerns about counterfeits and dosing accuracy.

Clinical Mechanism Of Action

How does sildenafil actually produce an erection?

Sildenafil citrate blocks the enzyme phosphodiesterase‑5 (PDE‑5) in penile smooth muscle, which allows cyclic GMP (cGMP) to accumulate during sexual stimulation and promotes vasodilation and tumescence.

Onset is typically 30–60 minutes after oral dosing and duration is usually about 4–6 hours, though individual response varies.

PDE‑5 normally degrades cGMP; sexual arousal triggers nitric oxide (NO) release which raises cGMP, and sildenafil sustains that signal to maintain an erection.

Pharmacokinetics are straightforward: oral sildenafil is absorbed within 30–120 minutes and is metabolised primarily by CYP3A4 and to a lesser extent CYP2C9 in the liver.

Dose adjustments are recommended for significant hepatic or renal impairment and often for older adults because clearance decreases with age.

Fildena Extra Power tablets are labelled as containing sildenafil citrate at a 150 mg strength, and higher doses carry greater risks such as hypotension and visual changes compared with standard 25–100 mg dosing.

Pharmacokinetics (Concise)

Sildenafil is rapidly absorbed and metabolised by CYP3A4 and CYP2C9.

Onset is usually within an hour and effect duration is commonly 4–6 hours.

Adjust dose for hepatic or renal impairment and consider lower starting doses in the elderly.

Scope Of Approved And Off‑Label Use

People want to know whether Fildena Extra Power is approved in Canada and how clinicians use sildenafil off‑label.

Health Canada issues Drug Identification Numbers (DINs) for marketed products and only branded Viagra and Health Canada–approved generics carry DINs for ED treatment.

Fildena is commonly marketed internationally but is typically not listed among authorised Canadian brands and purchases from e‑shops may lack a Canadian DIN.

In Canadian practice, sildenafil is sometimes used off‑label in specialist care for pulmonary arterial hypertension or for Raynaud phenomenon, but these indications require different dosing and monitoring.

High‑dose 150 mg use is uncommon in Canadian formularies and provincial monographs typically recommend adherence to 25–100 mg strengths.

When dose escalation beyond standard monographs is considered, pharmacist consultation or specialist oversight is advised.

Dosage Strategy

One common patient question is, “Where should I start and when should the dose change?”

Standard Health Canada‑aligned dosing for erectile dysfunction starts at 50 mg taken about one hour before sexual activity and is adjusted to 25 mg or 100 mg based on efficacy and tolerability.

The labelled maximum is one dose per 24 hours.

Elderly patients (over 65) generally start at lower doses, often 25 mg, due to reduced clearance.

Hepatic or severe renal impairment calls for cautious dose reduction and gradual titration.

Concomitant use of potent CYP3A4 inhibitors (for example, certain macrolides or systemic azole antifungals) requires dose reduction or avoidance because they raise sildenafil exposure.

Fildena Extra Power 150 mg is marketed for people who fail lower doses, but Canadian pharmacists and provincial formularies usually advise against routine use without specialist oversight because of limited high‑quality evidence and higher adverse‑event risk.

Safety Protocols

Patients often worry about whether sildenafil is safe given heart conditions or other drugs.

Absolute contraindications aligned with Health Canada guidance include concurrent nitrates, recent myocardial infarction or stroke, unstable angina, severe hypotension, known sildenafil allergy, severe hepatic or renal impairment, retinitis pigmentosa, and use in minors or women for ED.

Community pharmacists routinely screen for nitrates and major cardiovascular risk factors before dispensing sildenafil.

Common adverse effects reported in post‑market data include headache, flushing, nasal congestion, dyspepsia, visual disturbances, and myalgia.

Serious but rare events include non‑arteritic anterior ischaemic optic neuropathy (NAION), prolonged priapism lasting more than four hours, and significant hypotension which require immediate medical attention.

Risk mitigation in practice includes a medication review, use of contraindication checklists at community chains, documenting DINs for approved products, and advising patients to avoid unverified online sources to reduce counterfeit risk.

Interaction Mapping

Many questions arise about foods, supplements and common drugs that affect sildenafil.

High‑fat meals can delay sildenafil absorption and onset, which matters when patients take it after a heavy Canadian dinner or fast‑food meal.

Grapefruit juice may increase sildenafil exposure by inhibiting CYP3A4 and patients are advised to avoid it close to dosing.

Health Canada flags nitrates as an absolute contraindication because combination with sildenafil can cause life‑threatening hypotension.

Alpha‑blockers used for benign prostatic hyperplasia increase the risk of orthostatic hypotension when combined with sildenafil, so blood pressure monitoring and staggered dosing are recommended.

Potent CYP3A4 inhibitors such as ketoconazole or ritonavir markedly increase sildenafil levels and require dose reductions or avoidance.

Over‑the‑counter products, recreational nitrates (poppers) and unlabelled herbal ED supplements can interact dangerously, so pharmacists should query all OTC and recreational drug use before dispensing.

Patient Experience Analysis

Privacy, cost and convenience drive many patient choices for ED treatment in Canada.

Recent Canadian patient surveys and pharmacy feedback from 2021–2024 indicate a strong preference for discreet care and cost savings, with many patients choosing generics when DIN‑declared products are available.

Willingness to use international e‑shops rises when domestic cost or access barriers exist.

Online forums and social media report mixed experiences: some users report perceived potency with Fildena Extra Power after lower‑dose failures, while others note inconsistent effects or troubling side effects consistent with non‑standard dosing.

Community pharmacists report encountering imported pills without DINs and flag these for extra counselling and referral to prescribers when appropriate.

Virtual care uptake for ED assessment is high, but pharmacists emphasise in‑person review when polypharmacy or cardiovascular risk is present.

Distribution And Pricing Landscape

Where can Canadians buy sildenafil and what are the risks with non‑DIN sources?

Health Canada–approved sildenafil products are distributed through national pharmacy chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs, which require prescriptions and keep DIN records.

Canadian e‑pharmacies may list approved generics, and provincial formularies like Ontario Drug Benefit, BC PharmaCare and RAMQ have specific coverage criteria and may require special authorizations.

Purchases from international e‑shops listing Fildena often bypass DIN verification, creating counterfeit and unregulated supply risks.

In our online pharmacy, fildena extra power is available without a prescription, with discreet delivery to Canada (English) in 5–14 days.

Cross‑border price differences and US discount programs sometimes make US‑sourced medications appear cheaper, but Canadians buying from outside sources must ensure authenticity and comply with import rules.

Alternative Options

Patients frequently ask which ED medicine fits their lifestyle best.

DIN‑approved alternatives in Canada include originator Viagra (sildenafil) and Health Canada–approved sildenafil generics at 25, 50 and 100 mg strengths, tadalafil (Cialis), vardenafil (Levitra), and avanafil where available.

Tadalafil’s advantage is longer duration, lasting up to 36 hours for many patients, which suits spontaneous plans or daily low‑dose regimens.

Sildenafil’s pros are a well‑studied evidence base and predictable onset; its cons are a shorter duration and possible food interactions.

Vardenafil and avanafil may offer faster onset in some users, but availability varies by province and product.

When choosing an alternative, match priorities such as on‑demand versus daily use, comorbidities, co‑medications, cost and provincial coverage, and always verify DIN approval.

Regulatory Status

How does Health Canada decide what can be sold in Canada?

Health Canada requires pre‑market evidence of safety, efficacy and quality before granting a market authorisation and issuing a Drug Identification Number (DIN).

Products without a DIN are not authorised for sale in Canada and may lack bilingual labelling and Canadian patient information.

Canadian labelling rules mandate bilingual (English/French) labelling and specific patient information on approved products, while imported products like Fildena Extra Power commonly lack DINs and bilingual labelling.

Provincial drug benefit plans reimburse only DIN‑approved products listed on their formularies, which affects patient access and cost.

Consolidated FAQ

Q1: Is Fildena Extra Power approved in Canada?

A1: Fildena Extra Power is widely marketed internationally but typically lacks a Canadian DIN and is not listed among authorised Canadian brands; obtain ED medicines from DIN‑approved products via prescription.

Q2: Can I take 150 mg if 100 mg fails?

A2: Standard guidance recommends specialist review before exceeding 100 mg per day due to increased adverse effects; 150 mg is not standard in Canadian monographs and evidence is limited.

Q3: Are online purchases safe?

A3: Buying from verified Canadian pharmacies with DIN‑listed products is the safest option; international e‑shops can pose counterfeit and dosing risks and may not comply with import regulations.

Q4: Will provincial plans cover sildenafil?

A4: Coverage varies by province and criteria; provincial formularies such as Ontario Drug Benefit, BC PharmaCare and RAMQ have specific rules — check formularies for DIN‑listed products and special authorizations.

Q5: What should I tell my pharmacist?

A5: Disclose nitrates or nitrate‑containing products, cardiovascular history, all prescription and over‑the‑counter medications, herbal supplements and recreational drug use.

Visual Guide

Designers and clinic staff ask for clear visuals to aid counselling and web scanning.

1) Dosage Flowchart: Start 50 mg → Assess Response → Adjust To 25 mg Or 100 mg → Specialist Review Before >100 mg.

Caption: “Sildenafil titration pathway; Fildena Extra Power is higher‑dose and requires oversight.”

2) Provincial Coverage Map: Colour‑code provinces for ODB, PharmaCare, RAMQ criteria and where DINs are required.

Caption: “Provincial formularies and reimbursement for DIN‑approved sildenafil.”

3) Purchase Channel Risk Matrix: Licensed Canadian Pharmacies Vs International E‑Shops Vs Unregulated Vendors.

Caption: “Authenticity and safety trade‑offs when buying ED medication.”

4) Quick Counselling Card For Pharmacists: Nitrates Check, BP Check, Food Interactions, Side‑Effect Red Flags.

Caption: “Pharmacist checklist for sildenafil dispensing.”

Include icons for DIN, bilingual labelling and counterfeit risk to improve scanability.

Storage And Transport

Patients often wonder how to keep tablets safe while travelling across Canada.

Store sildenafil tablets, including Fildena Extra Power, at room temperature between 15–30°C away from moisture and direct heat, in line with label guidance.

Keep tablets in the original blister or container to preserve labelling, batch information and any DIN where present.

Sildenafil does not require cold‑chain refrigeration; only certain compounded or specialty formulations may have special handling instructions.

When crossing provincial or international borders, carry the original prescription and packaging and be aware of import rules.

Avoid leaving tablets in hot cars during Canadian summers where temperatures can exceed safe storage ranges.

Guidelines For Proper Use

What should a pharmacist tell a first‑time sildenafil user in Canada?

Pharmacists advise an initial medical evaluation for cardiovascular risk and a full medication reconciliation including nitrates, alpha‑blockers and CYP3A4 inhibitors.

Counselling should cover onset (30–60 minutes), the effect of food (high‑fat meals delay onset), and red flags such as prolonged erection for more than four hours or sudden visual loss.

Use DIN‑confirmed products and document counselling in the pharmacy record or the patient medication profile.

Provincial health authorities in Ontario, British Columbia and Quebec emphasise prescription‑only access and DIN verification for formulary coverage and recommend specialist referral for dose escalation beyond standard monographs.

Practical Checklist For Patients: keep an up‑to‑date medication list, avoid nitrates and poppers, report visual changes or priapism immediately, and purchase from licensed pharmacies with DIN labelling.

Delivery Across Canada (English)

Closing Safety Notes

If you are considering higher‑dose sildenafil because 100 mg was ineffective, consult a clinician before changing dose.

Report any sudden visual changes, chest pain, fainting, or erections lasting more than four hours to emergency care immediately.

Always confirm DINs and bilingual labelling when purchasing in Canada and discuss interactions with your pharmacist.

For patients using multiple antihypertensives or alpha‑blockers, request blood pressure monitoring and pharmacist counselling before first dose.

When in doubt about product authenticity or dose, return the product to a licensed pharmacy for assessment.